|
SAN DIEGO--(BUSINESS WIRE)--$ARCT #ClinicalTrial--Arcturus Therapeutics
Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a... Arcturus Therapeutics, Business Wire, Health care, JPMorgan Chase & Co, Nasdaq, NASDAQ:ARCT |
| More about this | |
|
|
|
|
| |